RESPONSE BIOMEDICAL HITS KEY MILESTONE IN 3M COLLABORATION FOR INFECTION PREVENTION

Response Biomedical Corp. (TSX-V: RBM, OTCBB: RPBIF) announced today that it has met a key development milestone as part of the co-development agreement with 3M Health Care announced on November 29, 2004. Under the agreement, 3M Health Care is funding the development of a new rapid, point-of-care microbiology test in the area of infection prevention based on Response Biomedical's RAMP technology. This collaboration is aimed at introducing a product portfolio to improve the outcome of patients entering the hospital system.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-22-2005/0004091900&EDATE=)